Boston Scientific Receives the US FDA's 510(k) Clearance for its LUX-Dx Insertable Cardiac Monitor System
Shots:
- LUX-DxICM System is a dual-stage algorithm diagnostic device implanted in patients to identify AF- atrial flutter- rhythm pause- bradycardia- and tachycardia episodes and detect arrhythmias when established thresholds or parameters are exceeded
- The dual-stage algorithm verifies arrhythmias before an alert is sent to clinicians- thereby providing actionable data for clinical decision-making. Additionally- after implant- patients are provided with a mobile device preloaded with the MyLUX app which connects via Bluetooth to their ICM device
- The app transmits device data daily/ as needed- to the LATITUDE Clarity Data Management System website providing remote programming capabilities to the device that enables physicians to adjust event detection settings without an in-person patient appointment
Click here to read full press release/ article | Ref: Boston Scientific | Image: The Boston Globe
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com